New study aims to uncover the genetics of anorexia and other eating disorders
On May 19, 2025, researchers at the Broad Institute Ben Neale and Mark Daly are co-leading the study,…
Regeneron to Acquire 23andMe® for $256 Million
On May 19, 2025, Regeneron Pharmaceuticals announced it has been named the successful bidder in the bankruptcy auction…
Biotechnology | Diagnostics | Disease | Genomics | Oncology | Therapeutics
Jumping genes Alters the Genome
On May 19, 2025, researchers from the Karlsruhe Institute of Technology (KIT) announced they have have discovered how…
Biology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
FDA clears first blood test for Alzheimer’s detection
On May 16, 2025, the U.S. Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose…
Woman dies of Creutzfeldt-Jakob almost 50 years after taking prion-contaminated growth hormone
On May 15, 2025, a University of Colorado–led case report in Emerging Infectious Diseases, describes a 58-year-old woman…
Disease | FDA | Neurology | Pharmaceutical | Therapeutics
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine
On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…
WHO Report warns of slowing global health gains
On May 15, 2025, the World Health Organization (WHO) announced it has published its World health statistics report…
World’s first patient treated with personalized CRISPR gene editing therapy at Children’s Hospital of Philadelphia
On May 15, 2025, a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine announced that a…
Sanofi to invest $20 billion in U.S. through 2030
On Mar. 14, 2025, Sanofi announced that it plans to invest at least $20 billion in the United…
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
On May 12, 2025, Roche announced it plans to invest up to $550 million in its Diagnostics site…
Genentech boosts U.S. presence with new $700 million North Carolina facility
On May 12, 2025, Genentech announced plans to invest more than $700 million in a new 700,000 square…
Middle East respiratory syndrome coronavirus – outbreak Reported in Saudi Arabia
On May 12, 2025, the the Ministry of Health (MoH) of the Kingdom of Saudi Arabia (KSA) reported…
Gates to give away virtually all of His wealth in the next twenty Years
On May 8, 2025, Bill Gates announced that he has decided to give away his money back to…
Gilead boosts planned U.S. investments by $11 billion amid tariff threat
On May 7, 2025, Gilead Sciences announced $11 billion in new planned investment in the U.S. to add…
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Infectious Disease | Medicine | Oncology | Therapeutics | Vaccine | Women's Health
Medical AI trained on whopping 57 million health records
On May 7, 2025, researchers at the University College London (UCL) and King’s College London announced that an…
EMA Uses AI to Leverage the power of data for public and animal health
On May 7, 2025, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published…
UT Southwestern and Children’s Health receive record-setting gift from Moody Foundation
On May 6, 2025, UT Southwestern Medical Center and Children’s Health℠ announced a historic nine-figure grant from the Moody Foundation…
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Infectious Disease | Materials | Medical Device | Nanotechnology | Neurology | NIH | Oncology | Therapeutics | Vaccine | Veterinary | Women's Health
Europe pledges half a billion euros to lure scientists as Trump battles universities
On May 5, 2025, The European Union (EU) and France announced half a billion euros worth of incentives…
Origins of common lung cancer that affects smokers discovered
On May 2, 2025, researchers at the Wellcome Sanger Institute, UCL, and the University of Cambridge announced they…
CDC Reports Twelve pediatric deaths from seasonal influenza virus infection
On May 2, 2025, the Centers for Disease Control reported twelve pediatric deaths associated with seasonal influenza virus…
Agriculture | Artificial Intelligence | Biotechnology | Cloning | Genomics | Infectious Disease | Nanotechnology | Neurology | NIH | Stem Cell | Therapeutics | U.S. Congress | Women's Health
NSF stops awarding new grants and funding existing ones
On May 1, 2025, the staff members at the U.S. National Science Foundation (NSF) were told to “stop…
Regulus Therapeutics announces Agreement to be Acquired by Novartis for $1.7 Billion
On Apr. 30, 2025, Regulus Therapeutics announced that it has entered into an agreement and plan of merger…
Merck Breaks Ground on $1 Billion Biologics Center in Wilmington, Delaware
On Apr. 29, 2025, Merck announced the start of construction for a $1 billion, 470,000 square-foot state-of-the-art biologics…
BioMADE Finalizes $132 Million National Security Investment in Demonstration-Scale Biomanufacturing Facility in Minnesota
On Apr. 29, 2025, BioMADE announced Maple Grove as the Minnesota site in its national network of bioindustrial…
Researchers develop model for real-time monitoring of kidney transplants
On Apr. 28, 2025, researchers at King’s College London, the University of Bristol and Great Ormond Street Hospital…
Merck to Acquire SpringWorks Therapeutics for $3.9 Billion
On Apr. 28, 2025, Merck and SpringWorks Therapeutics announced the companies have entered into a definitive agreement for…
Uganda declares end of Ebola outbreak
On Apr. 26, 2025, the World Health Organization (WHO) reported that Uganda has declared the end of the…
Amgen to expand Ohio biotech manufacturing plant
On Apr. 25, 2025, Amgen announced a $900 million expansion of its Ohio biotech manufacturing facility in New…
UW Medicine offers second drug for early Alzheimer’s
On Apr. 25, 2025, University of Washington announced that the Memory & Brain Wellness Center at Harborview Medical…
WHO announces new weapon in the global fight against malaria
On Apr. 22, 2025, Syngenta announced that its next-generation insecticide Sovrenta® has received pre-qualification by World Health Organization…